391 related articles for article (PubMed ID: 33347951)
41. Transcriptionally Distinct B Cells Infiltrate Allografts After Kidney Transplantation.
Zhang H; Cavazzoni CB; Hanson BL; Bechu ED; Podestà MA; Azzi J; Blazar BR; Chong AS; Kreisel D; Alessandrini A; Sage PT
Transplantation; 2023 Feb; 107(2):e47-e57. PubMed ID: 36398326
[TBL] [Abstract][Full Text] [Related]
42. Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection.
Schowengerdt KO; Fricker FJ; Bahjat KS; Kuntz ST
Transplantation; 2000 May; 69(10):2102-7. PubMed ID: 10852605
[TBL] [Abstract][Full Text] [Related]
43. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.
Steger U; Kingsley CI; Karim M; Bushell AR; Wood KJ
Transplantation; 2006 Nov; 82(9):1202-9. PubMed ID: 17102772
[TBL] [Abstract][Full Text] [Related]
44. Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients.
Londoño MC; Souza LN; Lozano JJ; Miquel R; Abraldes JG; Llovet LP; Quaglia A; Rimola A; Navasa M; Sánchez-Fueyo A
J Hepatol; 2018 Sep; 69(3):626-634. PubMed ID: 29709679
[TBL] [Abstract][Full Text] [Related]
45. Acute liver allograft rejection in the rat. An analysis of the immune response.
Egawa H; Martinez OM; Quinn MB; Villanueva JC; So S; Esquivel CO; Krams SM
Transplantation; 1995 Jan; 59(1):97-102. PubMed ID: 7839435
[TBL] [Abstract][Full Text] [Related]
46. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
47. Intragraft regulatory T cells in the modern era: what can high-dimensional methods tell us about pathways to allograft acceptance?
Bei KF; Moshkelgosha S; Liu BJ; Juvet S
Front Immunol; 2023; 14():1291649. PubMed ID: 38077395
[TBL] [Abstract][Full Text] [Related]
48. Galectin-1-induced tolerogenic dendritic cells combined with apoptotic lymphocytes prolong liver allograft survival.
Peng Y; Ye Y; Jia J; He Y; Yang Z; Zhu X; Huang H; Wang W; Geng L; Yin S; Zhou L; Zheng S
Int Immunopharmacol; 2018 Dec; 65():470-482. PubMed ID: 30390594
[TBL] [Abstract][Full Text] [Related]
49. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
[TBL] [Abstract][Full Text] [Related]
50. Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation.
Lohan P; Murphy N; Treacy O; Lynch K; Morcos M; Chen B; Ryan AE; Griffin MD; Ritter T
Front Immunol; 2018; 9():2666. PubMed ID: 30515159
[TBL] [Abstract][Full Text] [Related]
51. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
[TBL] [Abstract][Full Text] [Related]
52. Allo-specific immune response profiles indicative of acute rejection in kidney allografts using an in vitro lymphocyte culture-based model.
Mahakur S; Saikia B; Minz M; Minz RW; Nada R; Anand S; Sharma A; Jha V; Joshi N; Goel L; Arora A; Joshi K
Clin Exp Nephrol; 2018 Apr; 22(2):465-473. PubMed ID: 28849286
[TBL] [Abstract][Full Text] [Related]
53. Identification of the T cell clones expanding within both CD8(+)CD28(+) and CD8(+)CD28(-) T cell subsets in recipients of allogeneic hematopoietic cell grafts and its implication in post-transplant skewing of T cell receptor repertoire.
Horiuchi T; Hirokawa M; Kawabata Y; Kitabayashi A; Matsutani T; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB
Bone Marrow Transplant; 2001 Apr; 27(7):731-9. PubMed ID: 11360114
[TBL] [Abstract][Full Text] [Related]
54. T-cell exhaustion correlates with improved outcomes in kidney transplant recipients.
Fribourg M; Anderson L; Fischman C; Cantarelli C; Perin L; La Manna G; Rahman A; Burrell BE; Heeger PS; Cravedi P
Kidney Int; 2019 Aug; 96(2):436-449. PubMed ID: 31040060
[TBL] [Abstract][Full Text] [Related]
55. Donor-Reactive Regulatory T Cell Frequency Increases During Acute Cellular Rejection of Lung Allografts.
Greenland JR; Wong CM; Ahuja R; Wang AS; Uchida C; Golden JA; Hays SR; Leard LE; Rajalingam R; Singer JP; Kukreja J; Wolters PJ; Caughey GH; Tang Q
Transplantation; 2016 Oct; 100(10):2090-8. PubMed ID: 27077597
[TBL] [Abstract][Full Text] [Related]
56. Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts.
Mannon RB; Doyle C; Griffiths R; Bustos M; Platt JL; Coffman TM
Transplantation; 2000 May; 69(10):2137-43. PubMed ID: 10852613
[TBL] [Abstract][Full Text] [Related]
57. Liver allograft rejection in rats depleted of CD8+ cells.
Ninova DI; Ferguson DM; Wettstein PJ; Krom RA
Transpl Int; 1996; 9(5):499-505. PubMed ID: 8875794
[TBL] [Abstract][Full Text] [Related]
58. Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4(+)CD25(+)FoxP3(+) T regulatory cells.
Fujiki M; Esquivel CO; Martinez OM; Strober S; Uemoto S; Krams SM
Liver Transpl; 2010 Feb; 16(2):147-54. PubMed ID: 20104482
[TBL] [Abstract][Full Text] [Related]
59. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
60. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
